Literature DB >> 11225596

Sinus node recovery time assessment by the overdrive suppression test employing an intravenous injection of disopyramide phosphate.

T Ishikawa1, S Sumita, K Kimura, M Kikuchi, M Kosuge, T Endo, T Sugano, T Sigemasa, T Usui, S Umemura.   

Abstract

Although sinus node recovery time (SNRT) assessment by the overdrive suppression test (ODST) is important in detecting sick sinus syndrome (SSS), its sensitivity is still inadequate. We have evaluated the effect of intravenous injection (i.v.) of disopyramide phosphate (DP) in ODST. The subjects were 30 SSS patients (64.9 +/- 10.0 <SD> years old). If SNRT was <2,000 ms or the corrected SNRT (CSNRT) was < 1,000 ms, ODST was repeated after DP i.v. (2 mg. kg(-1), < or = 100 mg in total). Eleven normal subjects (59.3 +/- 9.0 years old) were also studied. Although SNRT was <2,000 ms or the CSNRT was < 1,000 ms in 13 of the 30 SSS patients (43%), SNRT was prolonged from 1,510 +/- 300ms to 3,400 +/- 1,160 ms (P<0.01), and CSNRT from 510 +/- 190 to 2,470 +/- 1,470 ms (P<0.01) after DP i.v. in these patients. Thus, SNRT was > or = 2,000 ms and the CSNRT was > or = 1,000 ms in 27 of 30 SSS patients (90%) after DP i.v. Using a combination of overdrive suppression and intravenous injection of disopyramide phosphate, the corrected sinus node recovery time was diagnostic (>525 ms) in 29 of the 30 patients (97%). In contrast, SNRT and CSNRT were shortened in the normal subjects during ODST after DP i.v. (P<0.01). The plasma concentration of DP estimated in nine patients was 4.1 +/- 1.0 microg.ml(-1). No serious side effect occurred. ODST employing DP i.v. is safe and seems to be highly effective in diagnosing SSS.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11225596     DOI: 10.1053/eupc.1999.0073

Source DB:  PubMed          Journal:  Europace        ISSN: 1099-5129            Impact factor:   5.214


  1 in total

1.  Severe iatrogenic bradycardia related to the combined use of beta-blocking agents and sodium channel blockers.

Authors:  Mihoko Kawabata; Yasuhiro Yokoyama; Takeshi Sasaki; Susumu Tao; Kensuke Ihara; Yasuhiro Shirai; Tetsuo Sasano; Masahiko Goya; Tetsushi Furukawa; Mitsuaki Isobe; Kenzo Hirao
Journal:  Clin Pharmacol       Date:  2015-02-16
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.